Insulin therapies - PowerPoint PPT Presentation


UK Survey on Endovascular Treatment of Acute Pulmonary Embolism

Acute pulmonary embolism (PE) is a significant issue in hospitalized patients, with current treatments focusing on anticoagulation and systemic thrombolysis. Surgical treatments have shown poor outcomes, leading to a rise in endovascular techniques aimed at reducing clot burden. A survey conducted i

0 views • 12 slides


Gene Therapy and Genome Editing Technology

This article provides insights into the status, regulatory considerations, and delivery methods of gene therapy and genome editing technologies. It discusses approved gene therapies in the US, human genome editing in clinical applications, and the regulatory authority of the FDA over gene therapy. T

2 views • 27 slides



Understanding Insulin Pump Therapy and Continuous Glucose Monitoring

Exploring the basics of insulin pump therapy, including the basal/bolus concept, operation of insulin pumps, advantages and limitations, day-to-day living with a pump, continuous glucose monitoring, and available systems.

1 views • 45 slides


Pharmaceutical Processing Equipment Market

Pharmaceutical processing includes a range of unit operations such as blending, milling, granulation, tablet pressing, coating, and filling, depending on the mode of delivery. With the growing adoption of continuous manufacturing and the rising number of novel therapies in clinical development, phar

1 views • 2 slides


Theresa S. Clark - Diabetes Educator Program Coordinator

Theresa S. Clark, MS, RD, LD, CDE, BC-ADM, is a dedicated Diabetes Educator and Program Coordinator at the Diabetes Resource Center in Hopkinsville, KY. She specializes in insulin therapies and teaches patients about insulin administration, carbohydrate counting, and mealtime insulin dosing. Certifi

1 views • 50 slides


The Impact of Smart Insulin Pens on Diabetes Care: Market Perspectives

The Global\u00a0Smart Insulin Pens Market size\u00a0is expected to be worth around\u00a0USD 350.6 Million by 2032\u00a0from\u00a0USD 111.2 Million in 2022, growing at a\u00a0CAGR of 12.50%\u00a0during the forecast period from 2023 to 2032.

0 views • 5 slides


Simulation-Based Training for Diabetes Care in Nursing

This simulation program, SCENS, focuses on enhancing nursing skills in managing diabetes-related complications such as hyper/hypoglycemia. The learning objectives include assessment, safe care provision, insulin administration, and effective communication. The simulation addresses the significant im

0 views • 17 slides


Overview of Anti-Diabetic Medication and Treatment Options

Anti-diabetic medications are used to treat diabetes by lowering glucose levels in the blood. There are various classes of drugs such as insulin, sensitizers, secretagogues, and more, each targeting different aspects of diabetes management. Type 1 diabetes requires insulin injections, while Type 2 d

0 views • 5 slides


United States Insulin Delivery Devices Market

\"The United States Insulin Delivery Devices Market is anticipated to exceed USD 15.97 Billion by 2033, growing at a CAGR of 10.34% from 2023 to 2033.\n\"\n

0 views • 4 slides


Understanding Diabetes: Types, Causes, and Prevention

Diabetes is a disease that affects how the body uses glucose, the main source of fuel. There are two main types of diabetes – Type 1 and Type 2. In Type 1 diabetes, the pancreas fails to produce insulin, while in Type 2, the body's cells do not respond properly to insulin. Uncontrolled diabetes ca

1 views • 14 slides


Human Insulin Gene Expression and Production

The process of cloning and expressing the human insulin gene has revolutionized the production of insulin for treating diabetes. By using genetically engineered bacteria, the human insulin gene is inserted, expressed, and purified to create insulin for therapeutic use. This innovation has overcome c

0 views • 20 slides


Insights into Insulin Costs and Diabetes Management in 2019

Medical innovation has revolutionized diabetes treatment, providing advanced insulin options for better blood sugar control and reducing complications. Improved medication adherence among diabetes patients can lead to significant cost savings and enhance health outcomes. Despite declining prices for

0 views • 10 slides


Diabetes Mellitus Type 1 Management Guidelines for Athletes

Diabetes Mellitus Type 1 is a chronic endocrine disorder characterized by hyperglycemia, absolute insulin deficiency, and autoimmune origins. This condition, more common among athletes, requires careful monitoring, insulin therapy, blood glucose management during exercise, and recognition of hypogly

0 views • 7 slides


Applications of Recombinant DNA Technology in Biotechnology

Explore the various applications of recombinant DNA technology in biotechnology, including insulin production for diabetes, enzyme production in food biotechnology, and the development of Golden Rice. Understand the process of insulin production using recombinant DNA technology and the significance

0 views • 32 slides


Understanding Type 1 Diabetes Pathophysiology and Etiology

Type 1 diabetes is characterized by absolute insulin deficiency, resulting from pancreatic beta cell destruction. It is prone to ketosis with a total deficit of circulating insulin, often due to autoimmune factors. The pathophysiology involves inflammation, immune-mediated cell destruction, and a ch

0 views • 13 slides


Regulation of Blood Glucose and Its Importance in Maintaining Health

Blood glucose regulation is crucial for energy supply in the body, particularly for brain function. Understanding the balance of glucose entering and leaving the blood through processes like absorption, glycogenolysis, and gluconeogenesis is vital. Hormones like insulin and glucagon play key roles i

0 views • 10 slides


Clinical Pharmacy Laboratory DM and Insulin Dosing Regimens

This comprehensive content covers various insulin dosing regimens used in clinical pharmacy laboratories for patients with diabetes mellitus. It includes examples of dosing regimens before meals and at bedtime, methods of insulin administration, vial images, mixing of different types of insulin, and

0 views • 14 slides


Insulin Pump Market

The\u00a0Global Insulin Pump Market size\u00a0is expected to be worth around\u00a0USD 15.5 Billion\u00a0by 2032, from\u00a0USD 4.8 Billion\u00a0in 2022, growing at a\u00a0CAGR of 12.8%\u00a0during the forecast period from 2023 to 2032.

0 views • 4 slides


Insulin Pens Market

The Insulin Pens Market is set to reach $6.73 bn by 2031, growing at 6.7% CAGR. Explore types, diabetes types, distribution channels, and healthcare settings.

0 views • 9 slides


The Insulin Pens Market is set to reach $6.73 bn by 2031

The Insulin Pens Market is set to reach $6.73 bn by 2031, growing at 6.7% CAGR. Explore types, diabetes types, distribution channels, and healthcare settings.

2 views • 9 slides


Smart Insulin Pens Market Set for Significant Expansion Amid Increasing Demand f

Smart Insulin Pens Market projected to reach $776.5 Mn by 2031, growing at a CAGR of 11.2% from 2024. Explore trends, drivers, and key players in the industry.\n

2 views • 9 slides


Understanding Diabetes Mellitus and Dental Plaque

Diabetes mellitus is an endocrine disorder characterized by high blood glucose levels due to insufficient insulin production or ineffectiveness. Type 1 diabetes is insulin-dependent and typically develops in childhood, while Type 2 diabetes is non-insulin dependent and often seen in overweight adult

0 views • 13 slides


Understanding and Managing Hyperglycemic Crises: DKA and HHS

Hyperglycemic crises such as Diabetic Ketoacidosis (DKA) and Hyperglycemic Hyperosmolar State (HHS) are life-threatening emergencies characterized by severe hyperglycemia and metabolic imbalances. DKA involves absolute or near-absolute insulin deficiency leading to ketone body production and systemi

0 views • 82 slides


Understanding Glycaemic Index in Nutrition and Health

Glycaemic Index (GI) measures how carbohydrate-containing foods affect blood glucose levels. High GI foods raise blood glucose rapidly, while low GI foods release glucose gradually. Studies track impacts on blood glucose levels, insulin secretion, fat storage, and pancreatic function. High GI foods

0 views • 15 slides


Adjuvant Therapies in Early Stage NSCLC: A Review

Examining the role of adjuvant therapies in stage IB-IIIA non-small cell lung cancer (NSCLC) post-surgery. Discussion includes the impact of chemotherapy and radiation therapy on overall survival rates and the historical context of adjuvant treatment decisions. Management strategies and consideratio

0 views • 30 slides


New Recommendations for Insulin Injection Technique and Needle Length - Guided by Expert Advice

The new recommendations emphasize using a 4mm needle for insulin injections to reduce the risk of incorrect administration. This needle length is suitable for children, adolescents, thin adults, and even obese patients. The guidelines also highlight the importance of perpendicular insertion of the n

0 views • 53 slides


Investigating Regulation of Aging by Transcription Factors DAF-16 and SKN-1 in the IIS Pathway in C. elegans

Aging regulation in eukaryotic organisms, particularly in Caenorhabditis elegans, is studied through the Insulin/Insulin-like Growth Factor-1 Signaling pathway. This research focuses on understanding how transcription factors DAF-16 and SKN-1 may act together to promote longevity by reducing the IIS

0 views • 11 slides


Understanding Brainspotting and Power Therapies for Trauma Healing

Participants in this workshop will explore Brainspotting (BSP) and other Power Therapies, learning about trauma, its effects, and the power of therapies such as EMDR, TFT/EFT, HAKOMI, PBSP, and more in addressing trauma and promoting healing through heightened bodily awareness and somatic memory ret

0 views • 19 slides


Pediatric Endocrinology Insulin Dosing Guide

Comprehensive reference for insulin dosing in pediatric endocrinology, covering onset, peak, and duration of action of various insulin preparations, guidelines for twice-daily dosing, managing Dawn Phenomenon and rebound hyperglycemia, and tips for multiple daily injections. Includes information on

0 views • 13 slides


Understanding Type 1 Diabetes: Causes, Symptoms, and Treatment

Type 1 diabetes is a condition where the pancreas fails to produce insulin, leading to high blood sugar levels. Without insulin, the body cannot use sugar for energy, resulting in various symptoms like hunger and fat burning. This article provides an overview of diabetes, how insulin works, and the

0 views • 13 slides


Understanding Diabetes Mellitus: Causes, Effects, and Management

Diabetes Mellitus is a condition characterized by high blood sugar levels due to insufficient insulin production or utilization. It affects various organs and requires careful management through lifestyle changes, medication, or insulin therapy. While the exact causes are still being researched, fac

0 views • 18 slides


Understanding Diabetes Mellitus in Dogs: Causes, Symptoms, and Treatment

Diabetes mellitus is a common endocrine disorder in dogs, characterized by symptoms like polyuria, polyphagia, and cataract development. The etiology involves insulin deficiency and insulin resistance, leading to hyperglycemia and various clinical manifestations. Diagnosis is based on symptoms, glyc

0 views • 9 slides


Stroke Hyperglycemia Insulin Network Effort (SHINE) Trial - Case #1 Control Group Protocol

The SHINE trial involves treatment protocols for hyperglycemia in stroke patients. In case #1, a patient is enrolled in the control group with specific timing requirements for checks, dosing, and insulin administration. Understanding the hourly and Q3 hourly check schedules is crucial for proper pat

0 views • 26 slides


Evolution of Glucose-Lowering Therapies in Primary Care Settings

Cardiovascular effects of older glucose-lowering therapies and the history of cardiovascular outcome trials are discussed in this educational slide module. It outlines the timeline of treatment options from the discovery of insulin to the introduction of various medications. Evidence regarding the c

0 views • 29 slides


Cardiovascular Outcomes Trials with GLP-1 Receptor Agonists

GLP-1 receptor agonists are newer non-insulin-based glucose-lowering therapies with demonstrated cardiovascular benefits. This educational module covers completed CVOTs involving GLP-1 receptor agonists, treatment options for type 2 diabetes, study designs, results, and a timeline of new treatment o

0 views • 47 slides


Understanding Canine Diabetes Mellitus: Causes, Symptoms, and Treatment

Canine diabetes mellitus is a common disease in dogs, primarily affecting middle-aged and older dogs. Unlike Type 2 diabetes in humans, dogs mainly experience insulin-dependent Type 1 diabetes. The condition results from beta cell dysfunction in the pancreas, leading to insulin deficiency. Causes in

0 views • 32 slides


Understanding Recombinant Plasmids in Bacterial Transformation

Recombinant plasmids play a crucial role in transforming bacteria for producing proteins like insulin. The process involves steps such as uptake through methods like heat shock or electroporation, culturing with antibiotics, and selection of transformed cells. By introducing human genes into bacteri

0 views • 15 slides


Understanding and Implementing Non-Drug Therapies for Pain in Older Adults

This resource provides information on the role of direct care workers in identifying and addressing pain in older adults, funded by The SCAN Foundation. It covers misconceptions about non-drug approaches to pain, various non-drug therapies like physical positioning and music, and tips on when to use

0 views • 47 slides


Revolutionizing Diabetes Care with Innovative Insulin Pump Solutions

Diabetes is a serious health condition affecting millions worldwide. This project aims to address the growing prevalence of diabetes by introducing advanced insulin pump technology. With a focus on the US market and a comprehensive strategy, including market information, components of insulin pumps,

0 views • 14 slides


Insulin Pens Market Expected to Surpass $6.73 Billion by 2031 Amid Growing Healt

Explore $6.73 billion Insulin Pens Market: Get exclusive insights on key market trends, segments, geographical analysis, & competitive analysis

1 views • 9 slides